A mouse model of tuberous sclerosis 1 showing background specific early post-natal mortality and metastatic renal cell carcinoma
Open Access
- 11 May 2005
- journal article
- research article
- Published by Oxford University Press (OUP) in Human Molecular Genetics
- Vol. 14 (13) , 1839-1850
- https://doi.org/10.1093/hmg/ddi190
Abstract
Tuberous sclerosis complex (TSC) is an autosomal dominant disorder caused by mutations in either the TSC1 or the TSC2 genes and characterized by the development of benign hamartomatous growths in multiple organ systems. We have inactivated Tsc1 in the mouse germ line by gene targeting in ES cells and confirmed that the mutant allele (Tsc1−) has a recessive embryonic lethal phenotype. We found that a significant number (∼27%) of heterozygous (Tsc1+/−) mice on the C57BL/6 background died before weaning (P=0.014) and show that these mice die in the post-natal period (P=0.033), normally at 1–2 days, from unknown causes. Forty-four percent (7/16) of Tsc1+/− mice on a C3H background developed macroscopically visible renal lesions as early as 3–6 months, increasing to 95% (37/39) by 15–18 months. Renal lesions progressed from cysts through cystadenomas to solid carcinomas. Eighty percent (16/20) of Tsc1+/− mice on a Balb/c background exhibited solid renal cell carcinomas (RCC) by 15–18 months and in 41%, RCCs were ≥5 mm, resulting in grossly deformed kidneys. Some RCCs had a sarcomatoid morphology of spindle cells in whorled patterns and metastasized to the lungs. We detected loss of the wild-type Tsc1 allele and elevated levels of p-mTOR and p-S6 in lesions from Tsc1+/− mice. This new murine model of hamartin deficiency exhibits a more severe phenotype than existing models.Keywords
This publication has 22 references indexed in Scilit:
- Unexpected embryonic stem (ES) cell mutations represent a concern in gene targeting: Lessons from “fierce” miceGenesis, 2004
- United at last: the tuberous sclerosis complex gene products connect the phosphoinositide 3-kinase/Akt pathway to mammalian target of rapamycin (mTOR) signallingBiochemical Society Transactions, 2003
- Mutational Analysis in a Cohort of 224 Tuberous Sclerosis Patients Indicates Increased Severity of TSC2, Compared with TSC1, Disease in Multiple OrgansAmerican Journal of Human Genetics, 2001
- Tsc2+/– mice develop tumors in multiple sites that express gelsolin and are influenced by genetic backgroundJournal of Clinical Investigation, 1999
- Comprehensive Mutation Analysis of TSC1 and TSC2—and Phenotypic Correlations in 150 Families with Tuberous SclerosisAmerican Journal of Human Genetics, 1999
- Two Genetically Separable Steps in the Differentiation of Thymic EpitheliumScience, 1996
- A site–directed chromosomal translocation induced in embryonic stem cells by Cre-loxP recombinationNature Genetics, 1995
- A germline insertion in the tuberous sclerosis (Tsc2) gene gives rise to the Eker rat model of dominantly inherited cancerNature Genetics, 1995
- Disruption of the proto-oncogene int-2 in mouse embryo-derived stem cells: a general strategy for targeting mutations to non-selectable genesNature, 1988
- Mutation and Cancer: Statistical Study of RetinoblastomaProceedings of the National Academy of Sciences, 1971